BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33420022)

  • 1. Host and viral determinants for efficient SARS-CoV-2 infection of the human lung.
    Chu H; Hu B; Huang X; Chai Y; Zhou D; Wang Y; Shuai H; Yang D; Hou Y; Zhang X; Yuen TT; Cai JP; Zhang AJ; Zhou J; Yuan S; To KK; Chan IH; Sit KY; Foo DC; Wong IY; Ng AT; Cheung TT; Law SY; Au WK; Brindley MA; Chen Z; Kok KH; Chan JF; Yuen KY
    Nat Commun; 2021 Jan; 12(1):134. PubMed ID: 33420022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.
    Puray-Chavez M; LaPak KM; Schrank TP; Elliott JL; Bhatt DP; Agajanian MJ; Jasuja R; Lawson DQ; Davis K; Rothlauf PW; Liu Z; Jo H; Lee N; Tenneti K; Eschbach JE; Shema Mugisha C; Cousins EM; Cloer EW; Vuong HR; VanBlargan LA; Bailey AL; Gilchuk P; Crowe JE; Diamond MS; Hayes DN; Whelan SPJ; Horani A; Brody SL; Goldfarb D; Major MB; Kutluay SB
    Cell Rep; 2021 Jul; 36(2):109364. PubMed ID: 34214467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.
    Partridge LJ; Urwin L; Nicklin MJH; James DC; Green LR; Monk PN
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.
    Peacock TP; Goldhill DH; Zhou J; Baillon L; Frise R; Swann OC; Kugathasan R; Penn R; Brown JC; Sanchez-David RY; Braga L; Williamson MK; Hassard JA; Staller E; Hanley B; Osborn M; Giacca M; Davidson AD; Matthews DA; Barclay WS
    Nat Microbiol; 2021 Jul; 6(7):899-909. PubMed ID: 33907312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
    Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
    J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate.
    Prieto-Fernández E; Egia-Mendikute L; Vila-Vecilla L; Bosch A; Barreira-Manrique A; Lee SY; García-Del Río A; Antoñana-Vildosola A; Jiménez-Lasheras B; Moreno-Cugnon L; Jiménez-Barbero J; Berra E; Ereño-Orbea J; Palazon A
    Emerg Microbes Infect; 2021 Dec; 10(1):1065-1076. PubMed ID: 34013835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.
    Edwards MJ; Becker KA; Gripp B; Hoffmann M; Keitsch S; Wilker B; Soddemann M; Gulbins A; Carpinteiro E; Patel SH; Wilson GC; Pöhlmann S; Walter S; Fassbender K; Ahmad SA; Carpinteiro A; Gulbins E
    J Biol Chem; 2020 Nov; 295(45):15174-15182. PubMed ID: 32917722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
    Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
    mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
    Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
    J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury.
    Yamaguchi T; Hoshizaki M; Minato T; Nirasawa S; Asaka MN; Niiyama M; Imai M; Uda A; Chan JF; Takahashi S; An J; Saku A; Nukiwa R; Utsumi D; Kiso M; Yasuhara A; Poon VK; Chan CC; Fujino Y; Motoyama S; Nagata S; Penninger JM; Kamada H; Yuen KY; Kamitani W; Maeda K; Kawaoka Y; Yasutomi Y; Imai Y; Kuba K
    Nat Commun; 2021 Nov; 12(1):6791. PubMed ID: 34815389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2.
    Rowland R; Brandariz-Nuñez A
    Microbiol Spectr; 2021 Oct; 9(2):e0119921. PubMed ID: 34494876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.
    Johnson BA; Xie X; Bailey AL; Kalveram B; Lokugamage KG; Muruato A; Zou J; Zhang X; Juelich T; Smith JK; Zhang L; Bopp N; Schindewolf C; Vu M; Vanderheiden A; Winkler ES; Swetnam D; Plante JA; Aguilar P; Plante KS; Popov V; Lee B; Weaver SC; Suthar MS; Routh AL; Ren P; Ku Z; An Z; Debbink K; Diamond MS; Shi PY; Freiberg AN; Menachery VD
    Nature; 2021 Mar; 591(7849):293-299. PubMed ID: 33494095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
    Clausen TM; Sandoval DR; Spliid CB; Pihl J; Perrett HR; Painter CD; Narayanan A; Majowicz SA; Kwong EM; McVicar RN; Thacker BE; Glass CA; Yang Z; Torres JL; Golden GJ; Bartels PL; Porell RN; Garretson AF; Laubach L; Feldman J; Yin X; Pu Y; Hauser BM; Caradonna TM; Kellman BP; Martino C; Gordts PLSM; Chanda SK; Schmidt AG; Godula K; Leibel SL; Jose J; Corbett KD; Ward AB; Carlin AF; Esko JD
    Cell; 2020 Nov; 183(4):1043-1057.e15. PubMed ID: 32970989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
    Sims AC; Burkett SE; Yount B; Pickles RJ
    Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
    J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.
    Hoffmann M; Kleine-Weber H; Pöhlmann S
    Mol Cell; 2020 May; 78(4):779-784.e5. PubMed ID: 32362314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
    Mondal T; Shivange G; Habieb A; Tushir-Singh J
    Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.